These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37726183)

  • 1. Corrigendum to "EASL clinical practice guidelines on the management of cystic liver diseases" [J Hepatol (77) 1083-1108].
    ;
    J Hepatol; 2023 Nov; 79(5):1338. PubMed ID: 37726183
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "EASL clinical practice guidelines on the management of hepatic encephalopathy" [J Hepatol 2022 (77) 807-824].
    ;
    J Hepatol; 2023 Nov; 79(5):1340. PubMed ID: 37758523
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma" [J Hepatol 69 (2018) 182-236].
    European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
    J Hepatol; 2019 Apr; 70(4):817. PubMed ID: 30739718
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis" [J Hepatol 69 (2018) 406-460].
    ;
    J Hepatol; 2018 Nov; 69(5):1207. PubMed ID: 30172388
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma" [J Hepatol (79) (2023) 181-208].
    ;
    J Hepatol; 2023 Nov; 79(5):1342. PubMed ID: 37748953
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "EASL Clinical Practice Guidelines on haemochromatosis" [J Hepatol 2022 (77) 479-502].
    ;
    J Hepatol; 2023 Nov; 79(5):1341. PubMed ID: 37770291
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "EASL clinical practice guidelines on sclerosing cholangitis" [J Hepatol (77) 761-806].
    ;
    J Hepatol; 2023 Nov; 79(5):1339. PubMed ID: 37735011
    [No Abstract]   [Full Text] [Related]  

  • 8. Erratum to "EASL Clinical Practice Guidelines on acute-on-chronic liver failure" [J Hepatol 79 (2023) 461-491].
    ;
    J Hepatol; 2024 Aug; 81(2):370. PubMed ID: 38772794
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to 'EASL recommendations on treatment of hepatitis C: Final update of the series
    European Association For The Study Of The Liver
    J Hepatol; 2023 Feb; 78(2):452. PubMed ID: 36464532
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI)" [J Clin Exp Hepatol 9 (2019) 74-98].
    Nagral A; Sarma MS; Matthai J; Kukkle PL; Devarbhavi H; Sinha S; Alam S; Bavdekar A; Dhiman RK; Eapen CE; Goyal V; Mohan N; Kandadai RM; Sathiyasekaran M; Poddar U; Sibal A; Sankaranarayanan S; Srivastava A; Thapa BR; Wadia PM; Yachha SK; Dhawan A
    J Clin Exp Hepatol; 2020; 10(1):99. PubMed ID: 32025169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EASL Clinical Practice Guidelines on the management of cystic liver diseases.
    ;
    J Hepatol; 2022 Oct; 77(4):1083-1108. PubMed ID: 35728731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
    Blond E; Disse E; Cuerq C; Drai J; Valette PJ; Laville M; Thivolet C; Simon C; Caussy C
    Diabetologia; 2017 Jul; 60(7):1218-1222. PubMed ID: 28352941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "Targeting the gut-liver axis in liver disease" [J Hepatol 67 (2017) 1084-1103].
    Wiest R; Albillos A; Trauner M; Bajaj JS; Jalan R
    J Hepatol; 2018 Jun; 68(6):1336. PubMed ID: 29655855
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to: "Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury" [J Hepatol (2019) 458-469].
    Ruart M; Chavarria L; Campreciós G; Suárez-Herrera N; Montironi C; Guixé-Muntet S; Bosch J; Friedman SL; Garcia-Pagán JC; Hernández-Gea V
    J Hepatol; 2020 Sep; 73(3):744. PubMed ID: 32605877
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Recipient characteristics and morbidity and mortality after liver transplantation" [J hepatol 69 (2018) 43-50].
    Asrani SK; Saracino G; O'Leary JG; Gonzalez S; Kim PT; McKenna GJ; Klintmalm G; Trotter J
    J Hepatol; 2018 Oct; 69(4):989. PubMed ID: 30097328
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Coffee and tea breaks for liver health" [J Hepatol 67 (2017) 221-223].
    Petta S; Marchesini G
    J Hepatol; 2017 Nov; 67(5):1122. PubMed ID: 28822589
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to 'Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model' [J Hepatol (2021) 1420-1433].
    Yang T; Poenisch M; Khanal R; Hu Q; Dai Z; Li R; Song G; Yuan Q; Yao Q; Shen X; Taubert R; Engel B; Jaeckel E; Vogel A; Falk CS; Schambach A; Gerovska D; Araúzo-Bravo MJ; Vondran FWR; Cantz T; Horscroft N; Balakrishnan A; Chevessier F; Ott M; Sharma AD
    J Hepatol; 2022 Jul; 77(1):270. PubMed ID: 35397937
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to: 'Hepatocyte-specific suppression of microRNA-221-3p mitigates liver fibrosis' [J Hepatol (2019) 722-734].
    Tsay HC; Yuan Q; Balakrishnan A; Kaiser M; Möbus S; Kozdrowska E; Farid M; Tegtmeyer PK; Borst K; Vondran FWR; Kalinke U; Kispert A; Manns MP; Ott M; Sharma AD
    J Hepatol; 2022 Jul; 77(1):269. PubMed ID: 35397938
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19].
    Salomone F; Pipitone RM; Longo M; Malvestiti F; Amorini AM; Distefano A; Casirati E; Ciociola E; Iraci N; Leggio L; Zito R; Vicario N; Saoca C; Männistö V; Pihlajamäki J; Qadri S; Yki-Järvinen H; Romeo S; Pennisi G; Cabibi D; Lazzarino G; Fracanzani AL; Dongiovanni P; Valenti L; Petta S; Volti GL; Grimaudo S
    J Hepatol; 2024 Feb; 80(2):378. PubMed ID: 38182533
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to: "Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis" [J Hepatol (2020) 241-251].
    Parisinos CA; Wilman HR; Thomas EL; Kelly M; Nicholls RC; McGonigle J; Neubauer S; Hingorani AD; Patel RS; Hemingway H; Bell JD; Banerjee R; Yaghootkar H
    J Hepatol; 2020 Dec; 73(6):1594-1595. PubMed ID: 32951912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.